Back to Search
PHILLIP COMPTON, M.D.
M.D.
Internal Medicine Physician
NPI: 1578591186IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hospitalist Physician
Hospitalist
Code: 208M00000X
16438(MS)
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
16438(MS)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
TULANE UNIVERSITY SCHOOL OF MEDICINE
Class of 1993
Research & Publications (20)
Correlates of hospitalization for alcohol-using methadone-maintained persons with physical health problems.
PMID 19129517·West J Nurs Res·2009
8-other
Methods for analyzing peptides and proteins on a chromatographic timescale by electron-transfer dissociation mass spectrometry.
PMID 18927556·Nat Protoc·2008
8-other
Safety of efalizumab therapy in patients with moderate to severe psoriasis: an open-label extension of a phase IIIb trial.
PMID 18636790·Drug Saf·2008
2-rct
Introduction of a self-report version of the Prescription Drug Use Questionnaire and relationship to medication agreement noncompliance.
PMID 18508231·J Pain Symptom Manage·2008
3-trial
Lack of effect of chronic dextromethorphan on experimental pain tolerance in methadone-maintained patients.
PMID 18507735·Addict Biol·2008
2-rct
Incidence and Treatment of Arterial Access Dissections Occurring during Cardiac Catheterization.
PMID 18254788·J Interv Cardiol·2008
8-other
Electrocardiogram characteristics of methadone and buprenorphine maintained subjects.
PMID 18956527·J Addict Dis·2008
8-other
Pain-related activation of leukocyte cellular adhesion molecules: preliminary findings.
PMID 18073496·Neuroimmunomodulation·2007
8-other
The role of urine toxicology in chronic opioid analgesic therapy.
PMID 18036504·Pain Manag Nurs·2007
6-review
Long-term continuous efalizumab therapy in patients with moderate to severe chronic plaque psoriasis: updated results from an ongoing trial.
PMID 16488337·J Am Acad Dermatol·2006
3-trial
Risk of noncardiac surgery after coronary drug-eluting stent implantation.
PMID 17056330·Am J Cardiol·2006
8-other
A review of malignancies observed during efalizumab (Raptiva) clinical trials for plaque psoriasis.
PMID 17033169·Dermatology·2006
4-observational
The addiction behaviors checklist: validation of a new clinician-based measure of inappropriate opioid use in chronic pain.
PMID 17000351·J Pain Symptom Manage·2006
3-trial
The effect of pain on leukocyte cellular adhesion molecules.
PMID 16581900·Biol Res Nurs·2006
6-review
Efalizumab retreatment in patients with moderate to severe chronic plaque psoriasis.
PMID 16488338·J Am Acad Dermatol·2006
3-trial
Acute pain management for patients receiving maintenance methadone or buprenorphine therapy.
PMID 16418412·Ann Intern Med·2006
5-case
An overview of the pharmacokinetics and pharmacodynamics of efalizumab: a monoclonal antibody approved for use in psoriasis.
PMID 16397279·J Clin Pharmacol·2006
6-review
Pharmacokinetics, bioavailability and opioid effects of liquid versus tablet buprenorphine.
PMID 16144748·Drug Alcohol Depend·2006
2-rct
Safety of efalizumab in patients with moderate to severe chronic plaque psoriasis: review of clinical data. part II.
PMID 16699903·J Cutan Med Surg·2005
4-observational
Clinical efficacy of efalizumab in patients with chronic plaque psoriasis: results from three randomized placebo-controlled Phase III trials: part I.
PMID 16699904·J Cutan Med Surg·2005
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 15286 COMMUNITY RD
GULFPORT, MS 39503 - Phone
- (228) 832-5151
Quick Facts
- NPI
- 1578591186
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 33
- Publications
- 20
Are you this provider?
Claim Your Profile